Home/ Supplements/ Lysine/ Lysine+

Lysine+

product on market Capsule Everyday Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

L-lysine, ascorbic acid, and zinc acetate are commonly used to support immune function and skin health. Research provides moderate evidence for their role in managing cold sores and supporting respiratory defenses. The overall evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Lysine+
Open Full PDF View on NIH DSLD →
Details

Label Data

1
Serving Size
60
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

455 mg (15% DV)
Market median: 500.0mg (159 products)
30 mg (50% DV)
Within RDA (0.3× RDA) 250 studies (A:6, B:97)
15 mg (50% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)

Other Ingredients

Gelatin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 1 capsule daily, or during a breakout take 1 capsule up to 8 times per day, or as advised by your doctor.

Warnings & Precautions

Caution: If you suffer from any health problems or on medications consult a physician before using.

Keep out of reach of children.

Always take only as directed. If symptoms persist or you have side effects see your healthcare professional.

Formulation Notes

Formulated to fight HSV1 and HSV2 herpes simplex virus. Cold sore complex

L-Lysine, Vitamin C & Zinc

Made in New Zealand from imported ingredients

Additional Information

Store in a cool dry place.

Metadata

Product Details

UPC / SKU9 421904 081826
DSLD Entry Date2024-01-24
Product TypeOther Combinations
FormCapsule
DSLD ID306093
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.